Adenoid Squamous Cell Carcinoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: ADN013 MIFTS: 41	Adenoid Squamous Cell Carcinoma Categories: Cancer diseases, Gastrointestinal diseases
Genes Tissues Related diseases Publications Pathways Drugs Expand all tables

Sources

Aliases & Classifications for Adenoid Squamous Cell Carcinoma

MalaCards integrated aliases for Adenoid Squamous Cell Carcinoma:

Name: Adenoid Squamous Cell Carcinoma ¹² ¹⁵

Adenocarcinoma with Squamous Metaplasia ¹² ⁷⁴

Acantholytic Squamous Cell Carcinoma ¹² ⁷⁴

Pseudoglandular Squamous Carcinoma ¹²

Adenoacanthoma ¹²

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Gastrointestinal diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:5524

NCIt ⁵¹ C4106 C4200

SNOMED-CT ⁶⁹ 15176003 85956000

UMLS ⁷⁴ C0334250 C0334393

Sources

Summaries for Adenoid Squamous Cell Carcinoma

Disease Ontology : ¹² A squamous cell carcinoma that is characterized by a tubular microscopic pattern and keratinocyte acantholysis.

MalaCards based summary : Adenoid Squamous Cell Carcinoma, also known as adenocarcinoma with squamous metaplasia, is related to angiosarcoma and eyelid carcinoma. An important gene associated with Adenoid Squamous Cell Carcinoma is CDH1 (Cadherin 1), and among its related pathways/superpathways are Keratinization and Cytoskeletal Signaling. The drugs Capecitabine and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include breast, skin and lung, and related phenotypes are Decreased shRNA abundance (Z-score < -2) and Decreased shRNA abundance (Z-score < -2)

Sources

Related Diseases for Adenoid Squamous Cell Carcinoma

Diseases related to Adenoid Squamous Cell Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 184)

#	Related Disease	Score	Top Affiliating Genes
1	angiosarcoma	30.1	KRT8 PECAM1 VIM
2	eyelid carcinoma	30.0	KRT20 KRT7
3	cystadenofibroma	29.9	KRT20 KRT7
4	adenosquamous carcinoma	29.7	KRT7 KRT8
5	mesothelioma, malignant	29.7	KRT20 KRT7 VIM
6	papillary adenocarcinoma	29.7	CDH1 KRT7 VIM
7	mammary paget's disease	29.6	KRT20 KRT7 KRT8
8	acantholytic squamous cell skin carcinoma	11.9
9	endometrial adenocarcinoma	11.6
10	ovary adenocarcinoma	11.1
11	squamous cell carcinoma	10.7
12	biphasic synovial sarcoma	10.2	CDH1 VIM
13	breast ductal carcinoma	10.2	CDH1 KRT8
14	endometrial adenosquamous carcinoma	10.2
15	goblet cell carcinoid	10.2	CDH1 KRT20
16	chondroid chordoma	10.2	CDH1 VIM
17	morpheaform basal cell carcinoma	10.2	CDH1 KRT20
18	keratosis	10.2
19	in situ carcinoma	10.2
20	pleomorphic liposarcoma	10.2	KRT8 VIM
21	odontoma	10.2	KRT8 VIM
22	long-chain 3-hydroxyacyl-coa dehydrogenase deficiency	10.2	KRT8 VIM
23	tubular adenocarcinoma	10.1	CDH1 KRT20
24	dendritic cell tumor	10.1	KRT20 VIM
25	villous adenoma	10.1	KRT20 KRT8
26	gastrointestinal system cancer	10.1	CDH1 KRT7
27	benign mesothelioma	10.1
28	pleomorphic adenoma carcinoma	10.1
29	adenocarcinoma	10.1
30	skin squamous cell carcinoma	10.1
31	pleomorphic adenoma	10.1
32	gallbladder squamous cell carcinoma	10.1
33	esophageal adenosquamous carcinoma	10.1
34	adenoma	10.1
35	actinic keratosis	10.1
36	renal pelvis adenocarcinoma	10.0	CDH1 KRT7
37	parachordoma	10.0	KRT7 VIM
38	secretory meningioma	10.0	KRT7 VIM
39	cervical squamous cell carcinoma	10.0	CDH1 KRT8
40	breast adenomyoepithelioma	10.0	CDH1 KRT7
41	nodular hidradenoma	10.0	KRT7 VIM
42	hidradenoma	10.0	KRT7 VIM
43	breast myoepithelial neoplasm	10.0	CDH1 KRT7
44	papillary adenoma	10.0	KRT7 VIM
45	benign metastasizing leiomyoma	10.0	KRT7 VIM
46	squamous cell carcinoma, head and neck	10.0
47	penile cancer, adult	10.0
48	monophasic synovial sarcoma	10.0	KRT7 VIM
49	cervical adenocarcinoma	10.0	KRT20 KRT7
50	metanephric adenoma	10.0	KRT7 VIM

Graphical network of the top 20 diseases related to Adenoid Squamous Cell Carcinoma:

Sources

Symptoms & Phenotypes for Adenoid Squamous Cell Carcinoma

GenomeRNAi Phenotypes related to Adenoid Squamous Cell Carcinoma according to GeneCards Suite gene sharing:

²⁷ (show all 16)

#	Description	GenomeRNAi Source Accession	Score	Top Affiliating Genes
1	Decreased shRNA abundance (Z-score < -2)	GR00366-A-1	9.77	PECAM1
2	Decreased shRNA abundance (Z-score < -2)	GR00366-A-134	9.77	VIM
3	Decreased shRNA abundance (Z-score < -2)	GR00366-A-14	9.77	PECAM1
4	Decreased shRNA abundance (Z-score < -2)	GR00366-A-180	9.77	PECAM1
5	Decreased shRNA abundance (Z-score < -2)	GR00366-A-211	9.77	PECAM1
6	Decreased shRNA abundance (Z-score < -2)	GR00366-A-212	9.77	VIM
7	Decreased shRNA abundance (Z-score < -2)	GR00366-A-68	9.77	KRT7
8	Decreased shRNA abundance (Z-score < -2)	GR00366-A-71	9.77	KRT7
9	Decreased shRNA abundance (Z-score < -2)	GR00366-A-72	9.77	KRT7
10	Decreased shRNA abundance (Z-score < -2)	GR00366-A-75	9.77	PECAM1
11	Decreased shRNA abundance (Z-score < -2)	GR00366-A-91	9.77	KRT7 PECAM1 VIM
12	Increased shRNA abundance (Z-score > 2)	GR00366-A-126	9.23	KRT8
13	Increased shRNA abundance (Z-score > 2)	GR00366-A-135	9.23	KRT7 KRT8
14	Increased shRNA abundance (Z-score > 2)	GR00366-A-192	9.23	KRT7 KRT8
15	Increased shRNA abundance (Z-score > 2)	GR00366-A-6	9.23	KRT8
16	Increased shRNA abundance (Z-score > 2)	GR00366-A-74	9.23	KRT7 KRT8

Sources

Drugs & Therapeutics for Adenoid Squamous Cell Carcinoma

Drugs for Adenoid Squamous Cell Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 28)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Capecitabine

Approved, Investigational

Phase 3,Phase 2

154361-50-9

60953

Synonyms:

(1-(5-Deoxy-b-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamate pentyl ester

(1-(5-Deoxy-b-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester

(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamate pentyl ester

(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester

(1-(5-Deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamate pentyl ester

(1-(5-Deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester

154361-50-9

158798-73-3

5'-Deoxy-5-fluoro-N-((pentyloxy)carbonyl)cytidine

5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine

AC1L1U83

AC1Q4KU8

Ambap154361-50-9

C110904

C12650

C15H22FN3O6

CAPE

Capecitabin

capecitabina

Capecitabina

capecitabine

Capecitabine

CAPECITABINE

Capécitabine

Capecitabine (JAN/USAN/INN)

Capecitabine [USAN]

capecitabinum

Capecitabinum

Capecitibine

Capiibine

Carbamic acid, (1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-, pentyl ester

Caxeta

CHEBI:31348

CHEMBL1773

CID60953

D01223

DB01101

FT-0082472

HSDB 7656

LS-59070

MolPort-005-938-254

N(4)-Pentyloxycarbonyl-5'-deoxy-5-fluorocytidine

Pentyl [1-(5-deoxy-b-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate

Pentyl [1-(5-deoxy-b-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamic acid

Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate

Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamic acid

Pentyl [1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate

Pentyl [1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamic acid

Pentyl 1-(5-deoxy-b-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate

Pentyl 1-(5-deoxy-b-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamic acid

Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate

Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamic acid

pentyl 1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate

Pentyl 1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate

Pentyl 1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamic acid

pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate

R340

R-340

RG-340

Ro 09-1978

Ro 09-1978/000

Ro-09-1978

Ro-09-1978/000

S1156_Selleck

UNII-6804DJ8Z9U

Xabine

Xeloda

Xeloda (TN)

Xeloda, Captabin, Capecitabine

ZINC03806413

Cisplatin

Approved

Phase 3,Phase 2

15663-27-1

2767 441203 84093

Synonyms:

(SP-4-1)-diamminedichloridoplatinum

(SP-4-1)-diamminedichloroplatinum

(SP-4-2)-diamminedichloridoplatinum

(SP-4-2)-diamminedichloroplatinum

Abiplatin

Biocisplatinum

Briplatin

CACP

Carboquone

CDDP

CHEBI:35852

CID441203

Cis Pt II

cis-[PtCl2(NH3)2]

cis-DDP

Cis-DDP

Cis-Diaminedichloroplatinum

cis-diamminedichloridoplatinum(II)

cis-Diamminedichloroplatinum

Cis-Diamminedichloroplatinum

cis-diamminedichloroplatinum(II)

cis-Dichlorodiammineplatinum(II)

Cismaplat

Cisplatin

Cisplatine

cisplatino

Cisplatino

Cisplatinum

Cisplatyl

Citoplationo

CPD0-1392

CPDC

CPDD

DB00515

DDP

DDPT

Diamminedichloroplatinum

EU-0100918

Lederplatin

nchembio773-comp1

Neoplatin

Peyrone's chloride

Peyrone's salt

Plastin

Platamine

Platiblastin

Platidiam

Platinex

Platinol

Platinol-AQ

Platinoxan

Platinum Ammine Chloride

Platinum Ammonium Chloride

Platinum Diamine Dichloride

Randa

trans-DDP

Trans-DDP

Trans-Diaminedichloroplatinum

trans-diamminedichloridoplatinum(II)

Trans-Diamminedichloroplatinum

Trans-Dichlorodiammine Platinum

Trans-Platinumdiammine Dichloride

Doxorubicin

Approved, Investigational

Phase 3

23214-92-8

31703

Synonyms:

(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside

(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside

(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside

(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside

(8S-cis)-10-((3-amino-2,3,6-Trideoxy-a-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione

(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione

(8S-cis)-10-((3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione

(8S-cis)-10-((3-amino-2,3,6-Trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione

111266-55-8

14-hydroxydaunomycin

14-Hydroxydaunomycin

14-hydroxydaunorubicine

14-Hydroxydaunorubicine

23214-92-8

23257-17-2

24385-08-8

25311-50-6

25316-40-9

25316-40-9 (hydrochloride)

29042-30-6

AC1L1M5T

AC1Q29OJ

adiblastine (hydrochloride salt)

ADM

ADR

adr iablatina (hydrochloride salt)

Adriablastin

Adriablastine

adriablastine (hydrochloride salt)

adriablatina (hydrochloride salt)

Adriacin (hydrochloride salt)

Adriamycin

Adriamycin PFS

Adriamycin PFS (hydrochloride salt)

Adriamycin RDF

Adriamycin RDF (hydrochloride salt)

Adriamycin semiquinone

Adriamycin Semiquinone

Adriblas tina

Adriblastin

Adriblastina

Adriblastina (hydrochloride salt)

Adriblastina (TN)

Adriblastine

adriblatina (hydrochloride salt)

Adrimedac

Aerosolized Doxorubicin

Baxter brand OF doxorubicin hydrochloride

Bedford brand OF doxorubicin hydrochloride

BPBio1_000502

BRD-K92093830-003-04-3

Bristol-myers squibb brand OF doxorubicin hydrochloride

BSPBio_000456

BSPBio_001031

C01661

C27H29NO11

Caelyx

CCRIS 739

Cell pharm brand OF doxorubicin hydrochloride

CHEBI:28748

CHEMBL179

CID31703

Columbia brand OF doxorubicin hydrochloride

Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74

Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120

D03899

DB00997

DM2

Doxil

Doxo

doxo Cell

doxo-Cell

Doxolem

doxorubicin

Doxorubicin

Doxorubicin (USAN/INN)

Doxorubicin [USAN:INN:BAN]

Doxorubicin citrate

Doxorubicin HCl

Doxorubicin hexal

Doxorubicin hydrochloride

Doxorubicin Hydrochloride

Doxorubicin hydrochloride (hydrochloride salt)

Doxorubicin NC

Doxorubicina

Doxorubicina [INN-Spanish]

Doxorubicina ferrer farm

Doxorubicina funk

Doxorubicina tedec

Doxorubicine

Doxorubicine [INN-French]

Doxorubicine baxter

Doxorubicin-hLL1

Doxorubicin-hLL1 conjugate

Doxorubicin-P4/D10

Doxorubicin-P4/D10 conjugate

Doxorubicinum

Doxorubicinum [INN-Latin]

Doxotec

DOX-SL

EINECS 245-495-6

Elan brand OF doxorubicin hydrochloride

Farmablastina (hydrochloride salt)

Farmiblastina

Ferrer brand OF doxorubicin hydrochloride

FI 106

Hexal brand OF doxorubicin hydrochloride

HMS2089H06

HSDB 3070

Hydrochloride, doxorubicin

Hydroxydaunomycin hydrochlor ide (hydrochloride salt)

Hydroxydaunomycin hydrochloride (hydrochloride salt)

Hydroxydaunorubicin

Hydroxydaunorubicin hydrochloride (hydrochloride salt)

JT9100000

Kenfarma brand OF doxorubicin hydrochloride

Lemery brand OF doxorubicin hydrochloride

LMPK13050001

LS-1029

LS-165655

Medac brand OF doxorubicin hydrochloride

MLS000759533

Myocet

NChemBio.2007.10-comp13

nchembio809-comp5

NCI-C01514

NDC 38242-874

Neocorp brand OF doxorubicin hydrochloride

NIOSH/JT9100000

NSC 123127

Onkodox

Onkoworks brand OF doxorubicin hydrochloride

Pfizer brand OF doxorubicin hydrochloride

Prasfarma brand OF doxorubicin hydrochloride

Prestwick0_000438

Prestwick1_000438

Prestwick2_000438

Prestwick3_000438

Probes1_000151

Probes2_000129

RDF Rubex

Resmycin

Ribodoxo

Ribosepharm brand OF doxorubicin hydrochloride

Rubex

Rubex (hydrochloride salt)

SMP1_000106

SPBio_002395

Tedec meiji brand OF doxorubicin hydrochloride

ThermoDox

TLC D-99

Triferric doxorubicin

UNII-80168379AG

Urokit doxo cell

Urokit doxo-cell

Paclitaxel

Approved, Vet_approved

Phase 3

33069-62-4

36314

Synonyms:

(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha R*,betaS*),11alpha,12alpha,12balpha))-beta-(Benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

157069-30-2

33069-62-4

5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

7 Epi taxol

7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.

7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.

7-epi-Paclitaxel

7-Epipaclitaxel

7-Epi-paclitaxel

7-epi-Taxol

7-Epitaxol

7-Epi-taxol

AB00513812

ABI 007

abi-007

ABI007

ABI-007

Abraxane

Abraxane (TN)

Abraxane I.V. Suspension

Abraxis BioScience brand of albumin-bound paclitaxel

AC1L1IOG

AC1L1VJI

AC1L9AVF

AC-675

ACon1_002231

albumin-bound paclitaxel

Ambotz33069-62-4

ANX-513

Anzatax

Asotax

BIDD:PXR0046

Bio-0076

Bio1_000362

Bio1_000851

Bio1_001340

Bio2_000416

Bio2_000896

BMS 181339-01

BMS-181339

BMS-181339-01

BPBio1_000320

BRD-A23723433-001-01-2

BRD-A28746609-001-04-0

BRD-K62008436-001-03-1

Bris taxol

Bristaxol

BSPBio_000290

BSPBio_001152

BSPBio_002614

C07394

C466458

C47H51NO14

Capxol

CCRIS 8143

CHEBI:103439

CHEBI:45863

CHEMBL100910

CHEMBL418410

CHEMBL48

CID36314

CID441276

CID4666

CID6713921

CID6915727

cMAP_000068

CPD-8718

D00491

DB01229

DHP-107

DHP-208

DivK1c_000441

DRG-0190

DTS-301

Ebetaxel

EmPAC

Epitaxol

EU-0101201

Genaxol

Genetaxyl

Genexol

Genexol-PM

HMS1362J13

HMS1568O12

HMS1792J13

HMS1922K08

HMS1990J13

HMS2090D07

HMS2093K15

HMS501G03

HSDB 6839

I06-0014

IDI1_000441

IDI1_002171

Intaxel

KBio1_000441

KBio2_000492

KBio2_002016

KBio2_002509

KBio2_003060

KBio2_004584

KBio2_005077

KBio2_005628

KBio2_007152

KBio2_007645

KBio3_000903

KBio3_000904

KBio3_001834

KBio3_002987

KBioGR_000492

KBioGR_001893

KBioGR_002509

KBioSS_000492

KBioSS_002016

KBioSS_002517

LipoPac

LMPR0104390001

Lopac0_001201

LS-31070

MBT 0206

MEGxp0_001940

Micellar Paclitaxel

Mitotax

MLS000863266

MLS001077297

MLS002154218

MLS002172439

MLS002695976

MolPort-001-742-627

MolPort-003-665-783

MolPort-003-932-365

MPI-5018

nab-paclitaxel

Nanotaxel

NCGC00024995-02

NCGC00024995-03

NCGC00024995-04

NCGC00024995-05

NCGC00024995-06

NCGC00024995-07

NCGC00164367-01

NCGC00164367-02

NCGC00164367-03

nchembio.188-comp1

nchembio.2007.34-comp9

nchembio.215-comp9

nchembio853-comp6

NCI60_000601

Neuro_000060

NINDS_000441

NK 105

Nova-12005

NP-010981

NSC 125973

NSC125973

NSC-125973

NSC358882

OAS-PAC-100

OncoGel

Onxal

Onxol

Onxol, Taxol, Nov-Onxol, Paclitaxel

P1632

Paclical

Pacligel

paclitaxel

Paclitaxel

Paclitaxel (JAN/USP)

Paclitaxel (JAN/USP/INN)

Paclitaxel (Taxol)

Paclitaxel [USAN:INN:BAN]

Paclitaxel, (4 alpha)-isomer

Paxceed

Paxene

Paxoral

Plaxicel

Praxel

Prestwick0_000155

Prestwick1_000155

Prestwick2_000155

Prestwick3_000155

Probes2_000350

QW 8184

S1150_Selleck

S-8184 Paclitaxel Injectable Emulsion

SDCCGMLS-0066823.P001

SDP-013

SMP1_000228

SMR000394086

SMR000857385

SPBio_000943

SPBio_002229

Spectrum_001536

SPECTRUM1503908

Spectrum2_000872

Spectrum3_001057

Spectrum4_001197

Spectrum5_001491

ST50306996

T 7402

T1912_SIGMA

T7191_SIGMA

T7402_SIGMA

TA1

TaxAlbin

Taxol

TAXOL

TAXOL (TN)

Taxol a

Taxol A

Taxol Konzentrat

TAXOL, 10-EPI,

Taxol, bris

Taxol.RTM. (Registered Trademark)

TXL

UNII-P88XT4IS4D

UPCMLD-DP108:001

UPCMLD-DP108:002

Vascular Wrap

weekly paclitaxel

Xorane

Yewtaxan

Gemcitabine

Approved

Phase 3,Phase 2

95058-81-4

60750

Synonyms:

103882-84-4

122111-03-9

2',2'-DFDC

2',2'-DiF-dC

2',2'-difluoro-2'-Deoxycytidine

2',2'-Difluoro-2'-deoxycytidine

2',2'-Difluorodeoxycytidine

2'-Deoxy-.beta.-D-2',2'-difluorocytidine

2'-Deoxy-2',2'-difluorocytidine

2'-Deoxy-2',2''-difluorocytidine-5'-O-monophosphate

2'-Deoxy-2'-difluorocytidine

4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one

4-amino-1-((2R,4R,5R)-3,3-difluoro-4-Hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one

4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one

95058-81-4

AB1004842

AC1L1TUQ

C07650

CCRIS 8984

CHEBI:175901

CHEMBL888

CID60750

Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine

D02368

DB00441

DDFC

DFdC

DFDC

DFdCyd

Folfugem

Gamcitabine

Gemcel

Gemcin

Gemcitabin

Gemcitabina

Gemcitabina [INN-Spanish]

gemcitabine

Gemcitabine

Gemcitabine (USAN/INN)

Gemcitabine HCl

Gemcitabine hydrochloride

Gemcitabine stereoisomer

Gemcitabine, (alpha-D-threo-pentofuranosyl)-isomer

Gemcitabine, (beta-D-threo-pentafuranosyl)-isomer

Gemcitabine, (D-threo-pentafuranosyl)-isomer

Gemcitabinum

Gemcitabinum [INN-Latin]

GemLip

Gemtro

Gemzar

Gemzar (hydrochloride)

GEO

HMS2089P10

HSDB 7567

Inno-D07001

LS-59139

LY 188011

LY188011

LY-188011

NCGC00168784-01

NChemBio.2007.10-comp25

nchembio.573-comp7

nchembio.90-comp2

NSC 613327

NSC613327

TL8005979

UNII-B76N6SBZ8R

Zefei

ZINC18279854

Doxil

Approved June 1999

Phase 3

31703

Antimetabolites, Antineoplastic

Phase 3,Phase 2

Liver Extracts

Phase 3,Phase 1

Antimetabolites

Phase 3,Phase 2

Anti-Bacterial Agents

Phase 3,Phase 2

Antibiotics, Antitubercular

Phase 3

Topoisomerase Inhibitors

Phase 3

Albumin-Bound Paclitaxel

Phase 3

Immunosuppressive Agents

Phase 3,Phase 2

Anti-Infective Agents

Phase 3,Phase 2

Antiviral Agents

Phase 3,Phase 2

Immunologic Factors

Phase 3,Phase 2,Phase 1

Sorafenib

Approved, Investigational

Phase 2

284461-73-0

216239 406563

Synonyms:

284461-73-0

4-(4-((((4-chloro-3-(Trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide

4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide

4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate

4-(4-(3-(4-chloro-3-Trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate

4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide

4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide

4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide

4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide

4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide

4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide

4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE

AB1004622

AC-1674

AC1L50CF

BAX

BAY 439006

BAY 43-9006

BAY 43-9006 (free base)

BAY 43-9006 tosylate salt

BAY 54-9085 (tosylate salt)

BAY-43-0006

BAY43-9006

BAY-43-9006

BAY-54-9085

Bio-0100

BRD-K23984367-001-01-8

CHEBI:47228

CHEBI:50924

CHEMBL1336

CID216239

D08524

DB00398

DB07438

EN002709

I06-0856

K00597a

Kinome_766

LS-186067

LS-187021

LS-187788

MolPort-003-850-270

N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea

N-(4-chloro-3-(Trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea

N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea

N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea

NCGC00167488-01

nchembio.117-comp17

Nexavar

NSC-724772

NSC747971

sorafenib

Sorafenib

Sorafénib

Sorafenib (INN)

Sorafenib [INN]

Sorafenib N-oxide

Sorafenib tosylate

sorafenibum

Sorafenibum

STK627350

UNII-9ZOQ3TZI87

ZINC01493878

Protein Kinase Inhibitors

Phase 2

Erlotinib Hydrochloride

Phase 2

183319-69-9

176871

Angiogenesis Inhibitors

Phase 2

Angiogenesis Modulating Agents

Phase 2

Pancrelipase

Approved, Investigational

Phase 1

53608-75-6

Immunoglobulins

Phase 1

Cola

Phase 1

Antibodies, Monoclonal

Phase 1

pancreatin

Phase 1

Antibodies

Phase 1

Interventional clinical trials:

(show all 12)

#	Name	Status	NCT ID	Phase	Drugs
1	Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer	Completed	NCT00363584	Phase 3	capecitabine
2	Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer	Completed	NCT00002493	Phase 3	cisplatin;doxorubicin hydrochloride
3	Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer	Completed	NCT00006027	Phase 3	cisplatin;paclitaxel
4	Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Biliary Cancer	Terminated	NCT00658593	Phase 3	capecitabine;gemcitabine hydrochloride
5	Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma	Completed	NCT01093222	Phase 2	Erlotinib Hydrochloride;Sorafenib Tosylate
6	S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma	Completed	NCT00238212	Phase 2	sorafenib tosylate
7	Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer	Completed	NCT00025467	Phase 2	thalidomide
8	S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma	Completed	NCT00033540	Phase 2	capecitabine;gemcitabine hydrochloride
9	Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery	Completed	NCT00331760	Phase 2	cisplatin
10	Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery	Withdrawn	NCT01859182	Phase 2	selumetinib;Akt inhibitor MK2206
11	RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma	Completed	NCT00101972	Phase 1
12	Gene Therapy in Treating Patients With Cancer	Completed	NCT00004178	Phase 1

Search NIH Clinical Center for Adenoid Squamous Cell Carcinoma

Sources

Genetic Tests for Adenoid Squamous Cell Carcinoma

Sources

Anatomical Context for Adenoid Squamous Cell Carcinoma

MalaCards organs/tissues related to Adenoid Squamous Cell Carcinoma:

⁴²

Breast, Skin, Lung, Liver, Ovary, Appendix, Thymus

Sources

Publications for Adenoid Squamous Cell Carcinoma

Articles related to Adenoid Squamous Cell Carcinoma:

(show all 46)

#	Title	Authors	Year
1	Characteristic imaging findings of acantholytic squamous cell carcinoma: a case report. ( 30798506 )	Kang JH...Hwang EH	2019
2	Acantholytic squamous cell carcinoma of the lung with marked lymphogenous metastases and high titers of myeloperoxidase-antineutrophil cytoplasmic antibodies: a case report. ( 29548309 )	Yorita K...Ito S	2018
3	Acantholytic squamous cell carcinoma of the gallbladder mimicking adenocarcinoma. ( 29671927 )	Yorita K...Kitagawa Y	2018
4	Acantholytic Squamous Cell Carcinoma and Salivary Duct Carcinoma Ex-pleomorphic Adenoma of the Submandibular Gland: A Report of Two Extremely Rare Cases with an Immunohistochemical Analysis. ( 30484070 )	Kusafuka K...Sugino T	2018
5	Adenoid Squamous Cell Carcinoma of Oral Cavity: a Case Report. ( 29492419 )	J C...Kendole RK	2018
6	Morphologic mimicry: acantholytic squamous cell carcinoma in nondermal locations-a literature review. ( 29744885 )	Mohammad M...Wilcox R	2018
7	Esophageal adenosquamous carcinoma mimicking acantholytic squamous cell carcinoma. ( 29085501 )	Matsukuma S...Takeo H	2017
8	Acantholytic squamous cell carcinoma is usually associated with hair follicles, not acantholytic actinic keratosis, and is not "high risk": Diagnosis, management, and clinical outcomes in a series of 115 cases. ( 27889291 )	Ogawa T...Fung MA	2017
9	Pulmonary acantholytic squamous cell carcinoma with focal signet ring cell morphology mimicking malignant mesothelioma on fine needle aspiration cytology: a case report. ( 25828595 )	Choi SE...Park HS	2016
10	Expression of desmosomal proteins in acantholytic squamous cell carcinoma of the skin. ( 25723181 )	Jur?i? V...Zidar N	2015
11	Pseudovascular adenoid squamous cell carcinoma of oral cavity: A mimicker of angiosarcoma. ( 22923907 )	Vidyavathi K...Deo R	2012
12	Adenoid squamous cell carcinoma of the oral cavity. ( 22808297 )	Terada T	2012
13	Collision of atypical fibroxanthoma and acantholytic squamous cell carcinoma in situ. ( 22728719 )	Hyatt AM...Spicknall KE	2012
14	Extramammary Paget's disease mimicking acantholytic squamous cell carcinoma in situ: a case report. ( 19615013 )	Du X...Cao S	2010
15	Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma. ( 18671846 )	Driemel O...Kosmehl H	2008
16	Pseudovascular adenoid squamous-cell carcinoma of the oral cavity--a report of two cases. ( 17071808 )	Zidar N...Dovsak D	2006
17	Adenoid squamous cell carcinoma of the larynx: an uncommon histological variant of squamous cell carcinoma. ( 16856971 )	Gonz?lez-Vela MC...B?scones M	2006
18	Primary adenoid squamous cell carcinoma of the oral cavity. ( 16445819 )	Kusafuka K...Kameya T	2006
19	Immunohistochemical and cytogenetic characterization of acantholytic squamous cell carcinoma of the breast. ( 15668805 )	Aulmann S...Sinn HP	2005
20	The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma. ( 11168756 )	Bayer-Garner IB...Smoller BR	2001
21	A case of adenoid squamous cell carcinoma of the breast skin. ( 11341233 )	Rosen PP	2000
22	A Case of Adenoid Squamous Cell Carcinoma of the Breast Skin. ( 11091718 )	Tazawa K...Tsukada K	1999
23	Fine-needle aspiration cytologic features of pseudovascular adenoid squamous-cell carcinoma of the lung. ( 10495320 )	Smith AR...Silverman JF	1999
24	Primary adenoid squamous cell carcinoma of the upper lip associated with a locoregional metastasis: a case report and review of the literature. ( 10319839 )	Blackburn TK...Conroy B	1999
25	Acantholytic squamous cell carcinoma of skin--a case report. ( 10028800 )	Rahman SB...Muzaffer M	1998
26	A case of pseudovascular adenoid squamous cell carcinoma of the skin with spindle cell pattern. ( 9350106 )	Yamamoto O...Yasuda H	1997
27	Mucosal adenoid squamous cell carcinoma of the head and neck. ( 8651637 )	Ferlito A...Carbone A	1996
28	Pseudovascular adenoid squamous cell carcinoma of the lung: clinicopathologic study of three cases and comparison with true pleuropulmonary angiosarcoma. ( 8163270 )	Nappi O...Wick MR	1994
29	Oral adenoid squamous cell carcinoma: a report of three cases and review of the literature. ( 8492207 )	Jones AC...Kerpel SM	1993
30	Pseudovascular adenoid squamous cell carcinoma of the skin. A neoplasm that may be mistaken for angiosarcoma. ( 1599022 )	Nappi O...Swanson PE	1992
31	Adenoid Squamous Cell Carcinoma. ( 28134144 )	Jayaraman M...Muthuswamy TC	1988
32	Adenoid squamous cell carcinoma of the skin overlying the right breast. An autopsy case clinically manifested with rapid growth and widely spreading metastases. ( 3825538 )	Watanabe K...Tsuda H	1986
33	Adenoid squamous cell carcinoma of the nasopharynx and neck region. ( 3518653 )	Zaatari GS...Santoianni RA	1986
34	A case of acantholytic squamous cell carcinoma derived from the acantholytic type of solar keratosis. ( 3546442 )	Uchiyama N...Shindo Y	1986
35	A clinicopathologic study of 21 cases of adenoid squamous cell carcinoma of the eyelid and periorbital region. ( 3976805 )	Caya JG...Weiner JM	1985
36	Adenoid squamous cell carcinoma of the penis. Report of a surgical case clinically manifested with rapid lung metastasis. ( 6670557 )	Watanabe K...Tsukahara K	1983
37	Adenosquamous carcinoma of skin appendages (adenoid squamous cell carcinoma, pseudoglandular squamous cell carcinoma, adenocanthoma of sweat gland of Lever) of the vulva: a clinical and ultrastructural study. ( 709534 )	Underwood JW...Okagaki T	1978
38	Adenoid squamous cell carcinoma of the oral mucosa: report of two autopsy cases. ( 922664 )	Takagi M...Ishikawa G	1977
39	Adenoid squamous cell carcinoma of the oral cavity: report of the first case arising in the tongue. ( 880122 )	Goldman RL...Sung M	1977
40	Adenoid squamous cell carcinoma of the vulva. ( 4810097 )	Lasser A...Morris JM	1974
41	Adenoid squamous-cell carcinoma of vermilion mucosa of lower lip. ( 4521951 )	Weitzner S	1974
42	Adenoid squamous cell carcinoma of the lip: report of cases. ( 4504554 )	Tomich CE...Hutton CE	1972
43	Adenoid squamous-cell carcinoma (adenocanthoma) of the oral labial mucosa. A clinicopathologic study of fifteen cases. ( 5285191 )	Jacoway JR...Boyers RC	1971
44	Multiple adenoid squamous cell carcinoma. ( 5093173 )	Wooldridge WE...Frerichs JB	1971
45	Adenoid squamous cell carcinoma (adenoacanthoma). A clinicopathologic study of 155 patients. ( 5927198 )	Johnson WC...Helwig EB	1966
46	ADENOID SQUAMOUS CELL CARCINOMA (ADENOACANTHOMA OF LEVER). REPORT OF SEVEN CASES AND REVIEW. ( 14107628 )	MULLER SA...WINKELMANN RK	1964

Sources

Genes for Adenoid Squamous Cell Carcinoma

Genes related to Adenoid Squamous Cell Carcinoma (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	CDH1	Cadherin 1	Protein Coding	21.91	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
2	VIM	Vimentin	Protein Coding	20.27	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
3	KRT20	Keratin 20	Protein Coding	20.08	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
4	PECAM1	Platelet And Endothelial Cell Adhesion Molecule 1	Protein Coding	15.05	DISEASES inferred ¹⁵
5	KRT7	Keratin 7	Protein Coding	14.76	DISEASES inferred ¹⁵
6	KRT8	Keratin 8	Protein Coding	14.69	DISEASES inferred ¹⁵

Sources

Variations for Adenoid Squamous Cell Carcinoma

Sources

Expression for Adenoid Squamous Cell Carcinoma

Search GEO for disease gene expression data for Adenoid Squamous Cell Carcinoma.

Sources

Pathways for Adenoid Squamous Cell Carcinoma

Pathways related to Adenoid Squamous Cell Carcinoma according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	Keratinization ⁶⁷ Show member pathways Formation of the cornified envelope ⁶⁷	11.89	KRT20 KRT7 KRT8
2	Cytoskeletal Signaling ⁴	11.51	CDH1 KRT20 KRT7 KRT8 VIM
3	Primary Focal Segmental Glomerulosclerosis FSGS ¹	11.19	KRT8 VIM
4	Cytoskeleton remodeling Neurofilaments ²³ Show member pathways Cytoskeleton remodeling Keratin filaments ²³	11.17	KRT7 KRT8 VIM
5	TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition ¹	10.41	CDH1 VIM

Sources

GO Terms for Adenoid Squamous Cell Carcinoma

Cellular components related to Adenoid Squamous Cell Carcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	extracellular exosome	GO:0070062	9.35	CDH1 KRT7 KRT8 PECAM1 VIM
2	cell periphery	GO:0071944	9.16	KRT8 PECAM1
3	intermediate filament	GO:0005882	8.92	KRT20 KRT7 KRT8 VIM

Biological processes related to Adenoid Squamous Cell Carcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	viral process	GO:0016032	9.43	KRT7 KRT8 VIM
2	keratinization	GO:0031424	9.33	KRT20 KRT7 KRT8
3	intermediate filament organization	GO:0045109	8.96	KRT20 VIM
4	cornification	GO:0070268	8.8	KRT20 KRT7 KRT8

Molecular functions related to Adenoid Squamous Cell Carcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	scaffold protein binding	GO:0097110	8.96	KRT8 VIM
2	structural molecule activity	GO:0005198	8.32	VIM

Sources

Sources for Adenoid Squamous Cell Carcinoma

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FDA Approved Drugs

²⁰ FMA

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ Genetics Home Reference

²⁷ GenomeRNAi

²⁸ GEO DataSets

²⁹ GO

³⁰ GTR

³¹ HGMD

³² HMDB

³³ HPO

³⁴ ICD10

³⁵ ICD10 via Orphanet

³⁶ ICD9CM

³⁷ IUPHAR

³⁸ KEGG

³⁹ LifeMap

⁴⁰ LncRNADisease

⁴¹ LOVD

⁴² MalaCards

⁴³ MedGen

⁴⁴ MedlinePlus

⁴⁵ MeSH

⁴⁶ MESH via Orphanet

⁴⁷ MGI

⁴⁸ miR2Disease

⁴⁹ NCBI Bookshelf

⁵⁰ NCI

⁵¹ NCIt

⁵² NDF-RT

⁵³ NIH Clinical Center

⁵⁴ NIH Rare Diseases

⁵⁵ NINDS

⁵⁶ Novoseek

⁵⁷ Novus Biologicals

⁵⁸ OMIM

⁵⁹ OMIM via Orphanet

⁶⁰ Orphanet

⁶¹ PathCards

⁶² PharmGKB

⁶³ PubMed

⁶⁴ PubMed Health

⁶⁵ QIAGEN

⁶⁶ R&D Systems

⁶⁷ Reactome

⁶⁸ Sino Biological

⁶⁹ SNOMED-CT

⁷⁰ SNOMED-CT via HPO

⁷¹ SNOMED-CT via Orphanet

⁷² TGDB

⁷³ Tocris

⁷⁴ UMLS

⁷⁵ UMLS via Orphanet

⁷⁶ UniProtKB/Swiss-Prot

⁷⁷ Wikipedia